Insider Trading Alert - OLED, RMD, DLPH, BWLD And WETF Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 21, 2013, 155 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $250.02 to $153,391,332.00.

Highlighted Stocks Traded by Insiders:

Universal Display Corporation (OLED) - FREE Research Report

Becker Leonard who is Director at Universal Display Corporation sold 2,500 shares at $38.03 on Nov. 21, 2013. Following this transaction, the Director owned 36,250 shares meaning that the stake was reduced by 6.45% with the 2,500 share transaction.

The shares most recently traded at $35.12, down $2.91, or 8.29% since the insider transaction. Historical insider transactions for Universal Display Corporation go as follows:

  • 4-Week # shares sold: 52,500
  • 12-Week # shares sold: 141,961
  • 24-Week # shares sold: 160,895

The average volume for Universal Display Corporation has been 683,100 shares per day over the past 30 days. Universal Display Corporation has a market cap of $1.8 billion and is part of the technology sector and computer hardware industry. Shares are unchanged year to date as of the close of trading on Thursday.

Universal Display Corporation engages in the research, development, and commercialization of organic light emitting diode (OLED) technologies and materials for use in flat panel display, solid-state lighting, and other product applications. The company has a P/E ratio of 81.0. Currently there are 6 analysts that rate Universal Display Corporation a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OLED - FREE

TheStreet Quant Ratings rates Universal Display Corporation as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and impressive record of earnings per share growth. However, as a counter to these strengths, we find that the stock itself is trading at a premium valuation. Get the full Universal Display Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

ResMed (RMD) - FREE Research Report

Hollingshead James who is President, Americas at ResMed sold 4,000 shares at $51.24 on Nov. 21, 2013. Following this transaction, the President, Americas owned 26,285 shares meaning that the stake was reduced by 13.21% with the 4,000 share transaction.

The shares most recently traded at $50.80, down $0.44, or 0.87% since the insider transaction. Historical insider transactions for ResMed go as follows:

  • 4-Week # shares sold: 31,563
  • 12-Week # shares sold: 32,563
  • 24-Week # shares sold: 33,063

The average volume for ResMed has been 1.2 million shares per day over the past 30 days. ResMed has a market cap of $7.3 billion and is part of the health care sector and health services industry. Shares are up 22.23% year to date as of the close of trading on Thursday.

ResMed Inc., through its subsidiaries, engages in the development, manufacture, and distribution of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. The stock currently has a dividend yield of 1.95%. The company has a P/E ratio of 23.6. Currently there are 7 analysts that rate ResMed a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RMD - FREE

TheStreet Quant Ratings rates ResMed as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full ResMed Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Delphi Automotive (DLPH) - FREE Research Report

Krol John A who is Director at Delphi Automotive sold 10,658 shares at $56.49 on Nov. 21, 2013. Following this transaction, the Director owned 81,321 shares meaning that the stake was reduced by 11.59% with the 10,658 share transaction.

The shares most recently traded at $57.75, up $1.26, or 2.18% since the insider transaction. Historical insider transactions for Delphi Automotive go as follows:

  • 4-Week # shares sold: 5,500
  • 12-Week # shares sold: 46,316
  • 24-Week # shares sold: 124,316

The average volume for Delphi Automotive has been 2.0 million shares per day over the past 30 days. Delphi Automotive has a market cap of $17.5 billion and is part of the consumer goods sector and automotive industry. Shares are up 51.27% year to date as of the close of trading on Thursday.

Delphi Automotive PLC, together with its subsidiaries, manufactures vehicle components; and provides electrical and electronic, powertrain, safety, and thermal technology solutions for the automotive and commercial vehicle markets worldwide. The stock currently has a dividend yield of 1.2%. The company has a P/E ratio of 16.9. Currently there are 10 analysts that rate Delphi Automotive a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DLPH - FREE

TheStreet Quant Ratings rates Delphi Automotive as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including weak operating cash flow and poor profit margins. Get the full Delphi Automotive Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Buffalo Wild Wings (BWLD) - FREE Research Report

Patterson Lee R. who is Sr. VP, Information Technology at Buffalo Wild Wings sold 216 shares at $149.19 on Nov. 21, 2013. Following this transaction, the Sr. VP, Information Technology owned 1,905 shares meaning that the stake was reduced by 10.18% with the 216 share transaction.

The shares most recently traded at $152.00, up $2.81, or 1.85% since the insider transaction. Historical insider transactions for Buffalo Wild Wings go as follows:

  • 4-Week # shares sold: 5,000
  • 12-Week # shares sold: 13,000
  • 24-Week # shares sold: 36,300

The average volume for Buffalo Wild Wings has been 355,600 shares per day over the past 30 days. Buffalo Wild Wings has a market cap of $2.7 billion and is part of the services sector and leisure industry. Shares are up 99.51% year to date as of the close of trading on Thursday.

Buffalo Wild Wings, Inc. engages in the ownership, operation, and franchise of restaurants primarily in the United States. It offers chicken and various food and beverage items, as well as serves bottled beers, wines, and liquor. The company has a P/E ratio of 40.6. Currently there are 8 analysts that rate Buffalo Wild Wings a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BWLD - FREE

TheStreet Quant Ratings rates Buffalo Wild Wings as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Buffalo Wild Wings Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

WisdomTree Investments (WETF) - FREE Research Report

Steinhardt Michael H who is Director at WisdomTree Investments sold 493,055 shares at $13.36 on Nov. 21, 2013. Following this transaction, the Director owned 19.0 million shares meaning that the stake was reduced by 2.53% with the 493,055 share transaction.

The shares most recently traded at $13.75, up $0.39, or 2.85% since the insider transaction. Historical insider transactions for WisdomTree Investments go as follows:

  • 4-Week # shares sold: 70,167
  • 12-Week # shares sold: 70,167
  • 24-Week # shares sold: 157,667

The average volume for WisdomTree Investments has been 1.5 million shares per day over the past 30 days. WisdomTree Investments has a market cap of $1.7 billion and is part of the financial sector and financial services industry. Shares are up 117.32% year to date as of the close of trading on Thursday.

WisdomTree Investments, Inc., through its subsidiaries, operates as an exchange-traded funds (ETFs) sponsor and asset manager. It offers ETFs in equities, currency, fixed income, and alternatives asset classes. The company has a P/E ratio of 45.1. Currently there are 4 analysts that rate WisdomTree Investments a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WETF - FREE

TheStreet Quant Ratings rates WisdomTree Investments as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity, expanding profit margins, good cash flow from operations and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full WisdomTree Investments Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Dow Tumbles 300 Points as Trump Ratchets Up China Trade Fight

Dow Tumbles 300 Points as Trump Ratchets Up China Trade Fight

Netflix Shares Hit All-Time High as Market Flounders

Netflix Shares Hit All-Time High as Market Flounders

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Snap Shares Plunge After Cowen Cuts Price Target

Snap Shares Plunge After Cowen Cuts Price Target

FANG Stocks Get Swept Up in Broader Market Selloff

FANG Stocks Get Swept Up in Broader Market Selloff